Jang, Wook,Moon, Young Ho,Ha, Tae Hee,Suh, Kwee Hyun
申请号：
AU2016345967
公开号：
AU2016345967A1
申请日:
2016.10.31
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention relates to a novel method for preparing thienopyrimidine compound having an activity of selectively inhibiting tyrosine kinase, specifically the mutant epidermal growth factor receptor tyrosine kinase； and a novel intermediate used therein. According to the method of the present invention, the industrial mass-production of the compound of Formula 1, which is useful as a therapeutic agent for non-small cell lung cancer induced by the mutant epidermal growth factor receptor tyrosine kinase, can be implemented more conveniently and efficiently than the conventional technology.
